Beckman Coulter Life Sciences and 10x Genomics partner to enable single cell workflow automation
Beckman Coulter Life Sciences and 10x Genomics, Inc. today announced a new partnership to expand automation solutions for single cell assay workflows.
Stay updated with breaking news from Ben Hindson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Beckman Coulter Life Sciences and 10x Genomics, Inc. today announced a new partnership to expand automation solutions for single cell assay workflows.
Beckman Coulter Life Sciences and 10x Genomics Partner to Enable Single Cell Workflow Automation INDIANAPOLIS and PLEASANTON, Calif. - - Beckman Coulter Life Sciences,...
Strengthen cellular analysis with cost-efficient multiomic readouts and streamlined workflows PLEASANTON, Calif., Sept. 14, 2023 /PRNewswire/ -- 10x Genomics, Inc. , a leader in single cell and...
/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the commercial availability of a new kit to...
Fintel reports that on July 13, 2023, Goldman Sachs maintained coverage of 10x Genomics Inc – (TXG) with a Sell recommendation. Analyst Price Forecast Suggests 0.79% Downside As of July 6, 2023, the average one-year price target for 10x Genomics Inc – is 59.07. The forecasts range from a low of 25.25 to a high […]